Create PPT on schizophrenia in detail for nursing students using recent guidelines, detailed diagram and mechanics
"schizophrenia"[MeSH Terms] AND "treatment guidelines"
schizophrenia nursing guidelines 2024 2025 pathophysiology dopamine treatment
Schizophrenia Nursing Guide
Presentation · PPTX
| # | Slide | Highlights |
|---|---|---|
| 1 | Title | Brain icon, guideline citations, date |
| 2 | Contents | Color-coded 10-topic index |
| 3 | Definition & Overview | Harrison's 22E quote, 4 key stats (prevalence, onset, burden) |
| 4 | Epidemiology & Risk Factors | Genetic risk ladder (1% → 50% MZ twins), 10 risk factors |
| 5 | Pathophysiology | 3-column diagram: Dopamine / Glutamate-NMDA / Serotonin-GABA mechanisms |
| 6 | Dopamine Pathway Diagram | All 4 pathways (mesolimbic, mesocortical, nigrostriatal, tuberoinfundibular) with clinical effects |
| 7 | Clinical Features | 3-column: Positive / Negative / Cognitive symptoms (DSM-5-TR aligned) |
| 8 | DSM-5-TR Criteria | Criterion A (5 items), Criteria B–F, 5 related disorders |
| 9 | Pharmacological Treatment | FGA vs SGA comparison, new 2025 drug KarXT (xanomeline) |
| 10 | Treatment Algorithm | 5-step INTEGRATE 2025 / VA-DoD 2025 flowchart |
| 11 | Nursing Assessment | MSE + Safety + Physical (3-column), AIMS scale, clozapine CBC |
| 12 | Nursing Diagnoses & Care Plan | 4 NANDA-I diagnoses with nursing interventions |
| 13 | Non-Pharmacological Interventions | CBTp, Family Psychoeducation, IPS, Aerobic Exercise, SST |
| 14 | Side Effects & Monitoring | NMS emergency box (HALT), EPS, metabolic, clozapine-specific |
| 15 | Complications & Prognosis | Rule of Thirds, illness course timeline (5 phases) |
| 16 | Special Populations | Pregnancy, elderly, adolescents, substance use comorbidity |
| 17 | Mnemonics & Quick Reference | SCHIZO nursing mnemonic, HALT for NMS, metabolic monitoring schedule |
| 18 | Key Takeaways | 6 evidence-based nursing practice points |
Create Ppt on schizophrenia in detail, using human brain diagram in pathophysiology and other needed areas, for nursing students, using recent guidelines
human brain dopamine pathway diagram schizophrenia SVG anatomy labeled 2024
"schizophrenia"[MeSH Terms] AND "treatment"[MeSH Terms]
Schizophrenia Nursing BrainDiagram
Presentation · PPTX
| # | Slide | Key Features |
|---|---|---|
| 1 | Title | Brain silhouette built from shapes (frontal/temporal/occipital lobes, cerebellum, VTA dot) |
| 2 | Table of Contents | Color-coded 12-topic index |
| 3 | Definition & Overview | Harrison's 22E quote + 4 stat boxes (prevalence, onset, USA cases, economic burden) |
| 4 | Epidemiology & Risk | Genetic risk ladder (1% → 50% MZ twins) + biological & environmental risk columns |
| 5 | Pathophysiology | 3-column: Dopamine Hypothesis / Glutamate-NMDA / Serotonin-GABA |
| 6 | 🧠 Human Brain Diagram | Full sagittal brain cross-section drawn in shapes — labeled frontal, parietal, temporal, occipital, cerebellum, brainstem, corpus callosum, VTA, nucleus accumbens, striatum, substantia nigra, hypothalamus, pituitary, thalamus — with all 4 dopamine pathways drawn as color-coded lines |
| 7 | Synapse Mechanism Diagram | Pre/post-synaptic neuron + DA vesicles drawn as shapes; shows normal state, schizophrenia (excess DA), FGA/SGA action, clozapine, partial agonists |
| 8 | Clinical Features | 3 columns: Positive / Negative / Cognitive symptoms |
| 9 | DSM-5-TR Criteria | Criterion A (5 items numbered), Criteria B-F, 5 related disorders row |
| 10 | Pharmacological Treatment | FGA vs SGA comparison table + KarXT 2024 new drug |
| 11 | Treatment Algorithm 2025 | 5-step INTEGRATE 2025 / VA-DoD CPG flowchart |
| 12 | Nursing Assessment | MSE + Safety Assessment + Physical Assessment (3 columns) |
| 13 | Nursing Diagnoses & Care | 4 NANDA-I diagnoses with 5 interventions each |
| 14 | Side Effects & Monitoring | NMS emergency HALT box + 4 SE categories (EPS, metabolic, clozapine, other) |
| 15 | Non-Pharmacological Interventions | CBTp, Family Psychoeducation, IPS, Exercise, SST |
| 16 | Prognosis & Summary | Rule of Thirds, complications, illness course timeline (5 phases) |
Create Ppt on schizophrenia in detail, using human brain diagram in pathophysiology and other needed areas, for nursing students, using recent guidelines
schizophrenia 2025 INTEGRATE guidelines treatment algorithm nursing
Schizophrenia Nursing Complete
Presentation · PPTX
| # | Slide | What makes it distinctive |
|---|---|---|
| 1 | Title | Brain silhouette with labeled VTA dot, frontal/temporal/parietal/occipital lobes drawn in shapes |
| 2 | Table of Contents | 15 color-coded topics with numbered badges |
| 3 | Definition & Overview | Harrison's 22E quote + 5 stat cards (prevalence, onset, sex ratio, USA burden, cost) |
| 4 | Epidemiology | Genetic risk ladder (1% → 50% MZ twins, heritability 80%) + biological and environmental risk factor columns |
| 5 | Pathophysiology | 3-column: Dopamine Hypothesis v.III / Glutamate-NMDA / Serotonin+GABA with KarXT 2024 noted |
| 6 | 🧠 Human Brain Diagram | Detailed sagittal brain with gyri/sulci texture, labeled lobes (frontal, parietal, temporal, occipital), cerebellum, brainstem, corpus callosum, and 9 labeled structures: VTA, Nucleus Accumbens, PFC, Striatum, Substantia Nigra, Hypothalamus, Pituitary, Thalamus, Amygdala, Hippocampus — all 4 dopamine pathways drawn as vivid colored arrows |
| 7 | Dopamine Pathways Table | Row-by-row comparison: pathway → origin → target → in schizophrenia → clinical symptoms → antipsychotic impact |
| 8 | Clinical Features | 3-column: Positive / Negative / Cognitive symptoms (18 items each) |
| 9 | DSM-5-TR Criteria | Criterion A (color-coded 1–5), Criteria B-F, 5 related disorders row |
| 10 | Pharmacological Treatment | FGA vs SGA with full drug list, KarXT 2024 FDA approval highlighted |
| 11 | Treatment Algorithm 2025 | 5-step INTEGRATE 2025 / VA-DoD CPG 2025 flowchart with connector arrows |
| 12 | Nursing Assessment | 3 columns: MSE / Safety (C-SSRS) / Physical (AIMS, labs) |
| 13 | Nursing Diagnoses | 4 NANDA-I diagnoses with 5 nursing interventions each |
| 14 | Side Effects & Monitoring | NMS emergency HALT banner + 4 SE boxes (EPS, metabolic, clozapine-specific, other) |
| 15 | Non-Pharmacological | CBTp, Family Psychoeducation, IPS, Aerobic Exercise, SST — 5 columns |
| 16 | Prognosis & Summary | Rule of Thirds (WHO 2025), complications, 5-phase illness timeline |
Create a print-friendly PDF version of this PPT for easy distribution to students
Schizophrenia Nursing Complete
PDF Document · PDF